Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanxiao Xu

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Chemical Communications (Cambridge, England)|September 23, 2025
Indole ring expansion into quinolines with TMSCCl<sub>3</sub>/TMSCBr<sub>3</sub>Zhixin Wang, Hanxiao Xu, Xuanzhen Han, et al.
Journal of Inflammation Research|October 13, 2025
A Conceptual Review of Gut, Skin, and Oral Microbiota in Autoimmune Bullous Diseases: From Dysbiosis to Therapeutic PotentialHanxiao Xu, Sizhe Li, Sihan Liu, et al.
Journal of Proteome Research|February 8, 2021
Protein-Protein Interaction Prediction Based on Spectral Radius and General Regression Neural NetworkHanxiao Xu, Da Xu, Naiqian Zhang, et al.
Experimental Hematology & Oncology|December 11, 2020
CD44 as a tumor biomarker and therapeutic targetHanxiao Xu, Mengke Niu, Xun Yuan, et al.
Molecules (Basel, Switzerland)|April 23, 2020
Protein-Protein Interactions Prediction Based on Graph Energy and Protein Sequence InformationDa Xu, Hanxiao Xu, Yusen Zhang, et al.
Organic Letters|October 2, 2024
Manganese-Catalyzed Cycloalkene Ring Expansion Synthesis of AzaheterocyclesZhixin Wang, Hanxiao Xu, Xuanzhen Han, et al.
Organic Letters|June 26, 2026
Visible-Light-Induced Radical C-N Coupling for Access to Hydrazine DerivativesXuanzhen Han, Hanxiao Xu, Zhixin Wang, et al.
Frontiers in Oncology|February 15, 2019
EYA2 Correlates With Clinico-Pathological Features of Breast Cancer, Promotes Tumor Proliferation, and Predicts Poor SurvivalHanxiao Xu, Ying Jiao, Ming Yi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 23, 2017
Targeting interlukin-6 to relieve immunosuppression in tumor microenvironmentQian Liu, Shengnan Yu, Anping Li, et al.
Experimental Hematology & Oncology|December 12, 2018
Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicineHanxiao Xu, Ying Jiao, Shuang Qin, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Chemical Communications (Cambridge, England)|September 23, 2025
Indole ring expansion into quinolines with TMSCCl<sub>3</sub>/TMSCBr<sub>3</sub>Zhixin Wang, Hanxiao Xu, Xuanzhen Han, et al.
Journal of Inflammation Research|October 13, 2025
A Conceptual Review of Gut, Skin, and Oral Microbiota in Autoimmune Bullous Diseases: From Dysbiosis to Therapeutic PotentialHanxiao Xu, Sizhe Li, Sihan Liu, et al.
Journal of Proteome Research|February 8, 2021
Protein-Protein Interaction Prediction Based on Spectral Radius and General Regression Neural NetworkHanxiao Xu, Da Xu, Naiqian Zhang, et al.
Experimental Hematology & Oncology|December 11, 2020
CD44 as a tumor biomarker and therapeutic targetHanxiao Xu, Mengke Niu, Xun Yuan, et al.
Molecules (Basel, Switzerland)|April 23, 2020
Protein-Protein Interactions Prediction Based on Graph Energy and Protein Sequence InformationDa Xu, Hanxiao Xu, Yusen Zhang, et al.
Organic Letters|October 2, 2024
Manganese-Catalyzed Cycloalkene Ring Expansion Synthesis of AzaheterocyclesZhixin Wang, Hanxiao Xu, Xuanzhen Han, et al.
Organic Letters|June 26, 2026
Visible-Light-Induced Radical C-N Coupling for Access to Hydrazine DerivativesXuanzhen Han, Hanxiao Xu, Zhixin Wang, et al.
Frontiers in Oncology|February 15, 2019
EYA2 Correlates With Clinico-Pathological Features of Breast Cancer, Promotes Tumor Proliferation, and Predicts Poor SurvivalHanxiao Xu, Ying Jiao, Ming Yi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 23, 2017
Targeting interlukin-6 to relieve immunosuppression in tumor microenvironmentQian Liu, Shengnan Yu, Anping Li, et al.
Experimental Hematology & Oncology|December 12, 2018
Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicineHanxiao Xu, Ying Jiao, Shuang Qin, et al.
Pageof 7